Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It seems the judge bought into this Claims Construction Brief

Thanks and agree but it does seem that there is a "tail wagging the dog" element given that there are a reported 16000 souls impacted by the decisions of an unchecked party of three.

I suppose that if they hold to the suggestion that they will be paying dividends rather than trying to invest, this stock could become very attractive to much needed institutional investors.

To repeat a line used often here... We shall see.

Share
New Message
Please login to post a reply